Archives
Angiotensin I Workflows for RAS Research
2026-09-15
Turn Angiotensin I into a controlled substrate for ACE activity studies, antihypertensive drug screening, and cardiovascular mechanism experiments. This practical guide combines peptide handling, assay controls, neuroendocrine study design, and a data-quality lesson from fluorescence spectroscopy research.
Angiotensin I (Human, Mouse, Rat): Research Guide
2026-09-15
Angiotensin I is a decapeptide precursor that connects renin activity to angiotensin II generation in renin-angiotensin system research. The A1006 product supports cardiovascular, neuroendocrine, and antihypertensive drug screening workflows when investigators distinguish the precursor from the active Ang II product.
Dual-Action Inhibitors and p38α Dephosphorylation
2026-09-14
The referenced preprint shows that selected kinase inhibitors can do more than block p38α MAP kinase catalysis: they can also accelerate WIP1-mediated dephosphorylation by reshaping the kinase activation loop. This structural mechanism provides a framework for designing experiments that distinguish direct active-site inhibition from phosphatase-assisted signal termination.
Toremifene Citrate: Practical ER Workflows
2026-09-14
Translate estrogen receptor pharmacology into reproducible cell-based, binding, and translational workflows with Toremifene Citrate. The guide emphasizes concentration design, matched tamoxifen comparisons, assay controls, and troubleshooting for breast cancer research.
GRE Combination Inhibits Melanogenesis: Study Analysis
2026-09-13
This study evaluates a composition of glabridin, resveratrol, and ellagic acid (GRE) across melanogenesis, oxidative-stress, and inflammation-related assays. Its main contribution is a multi-readout comparison linking reduced melanin and tyrosinase activity with suppression of CREB phosphorylation and MITF-associated signaling, while also identifying antioxidant and nitric oxide-lowering activity in vitro.
Bestatin Hydrochloride: A Conversion-Aware Assay Guide
2026-09-12
Bestatin hydrochloride, also known as Ubenimex, is a powerful probe for connecting aminopeptidase activity with neuronal signaling, angiogenesis inhibition, and tumor biology. This guide focuses on conversion-aware assay design, controls, and interpretation rather than repeating a conventional product summary.
Safe DNA Gel Stain for RNAi Gel Workflows
2026-09-11
Safe DNA Gel Stain supports safer DNA and RNA gel stain workflows for RNAi and developmental biology. This guide connects blue-light nucleic acid visualization with assay decisions inspired by MroGCL research in giant prawn spermatogenesis.
a-MSH, amide: A Causal Lens on Melanogenesis
2026-09-11
a-MSH, amide is an alpha-melanocyte-stimulating hormone amide for controlled melanogenesis studies. This article explains how to use it as a causal perturbation, interpret CREB/MITF evidence, and separate pigmentation from inflammatory readouts.
FAISL, Calpain 2, and FAK Stability in TNBC
2026-09-10
A 2024 Advanced Science study identifies FAISL as a long non-coding RNA that stabilizes focal adhesion kinase by blocking calpain 2-mediated proteolysis. By combining TCGA analysis, RNA immunoprecipitation sequencing, mechanistic cell studies, and nanoparticle-delivered siRNA, the work connects RNA-dependent protein stability with triple-negative breast cancer progression and metastasis.
Sulfo-NHS-LC-Biotin: Practical Labeling Guide
2026-09-10
Sulfo-NHS-LC-Biotin is a water-soluble, membrane-impermeable reagent for covalent biotinylation of accessible primary amines on proteins, peptides, and cell-surface proteins. This guide covers aqueous labeling, cleanup, and streptavidin capture while defining why the reagent is unsuitable for reversible or intracellular labeling.
BFH772 (VEGFR2 inhibitor): Workflow Guide
2026-09-09
BFH772 is a selective small-molecule VEGFR2 inhibitor for target-focused kinase, cellular, and angiogenesis research where organic-solvent stocks are acceptable. Its water insolubility, storage requirements, and lack of directly matched paper evidence make solvent control, fresh working solutions, and independent assay validation essential.
Bestatin, Amastatin, and Brain Angiotensin Signaling
2026-09-09
Harding and Felix used local aminopeptidase inhibition and microiontophoretic recording to test whether angiotensin II requires conversion to angiotensin III for neuronal activation. Their results support a sequential processing model in which aminopeptidase A participates in angiotensin II conversion, while bestatin-sensitive peptidase activity helps regulate the resulting signal.
Drug Response Metrics in Cancer Research
2026-09-08
Hannah Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central contribution is a more discriminating in vitro framework that separates growth inhibition from cell killing and emphasizes their distinct proportions and timing.
(S)-(+)-Methoprene Research Workflows
2026-09-08
Use (S)-(+)-Methoprene as a controlled juvenile hormone analog to connect Met receptor activation with larval-state maintenance, metamorphosis, and reproduction. A paper-guided workflow also shows how methoprene rescue experiments can separate upstream miRNA control of juvenile hormone biosynthesis from downstream receptor signaling.
Tomivosertib in Human DRG Neurons: Study Insights
2026-09-07
The reference study directly tested MNK inhibition in cultured human dorsal root ganglion neurons obtained during surgery for radiculopathy. Tomivosertib rapidly and reversibly reduced spontaneous neuronal activity while suppressing eIF4E phosphorylation, providing translational evidence that MNK signaling contributes to human nociceptor hyperexcitability.
605 records 8/41 page Previous Next First page 上5页 678910 下5页 Last page